Visuospatial Function in Parkinson's Disease

帕金森病的视觉空间功能

基本信息

项目摘要

DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a common age-related neurodegenerative disorder in which multiple aspects of visuospatial cognitive function are impaired. Spatial dysfunction arises from pathological changes in high- order association areas of the brain but also from defective input from lower-level visual processing areas. Deficits in vision are prevalent in PD but virtually nothing is known about the relation between vision, cognition, and daily function in this disorder. Also unknown are the cognitive sequelae of the side of initial motor impairment, despite PD nearly always having unilateral onset of neurodegeneration and unequivocal evidence linking spatial abnormalities to right-hemisphere dysfunction. We propose a multi-level approach to examining visuospatial dysfunction in PD. One major focus is on the visuospatial consequences of visual deficits, specifically the reduced signal strength that results from contrast sensitivity loss. An innovative aspect of the study is our use of frequency doubling technology and optical coherence tomography to assess visual (including retinal) function. A second focus is on the side of onset of motor impairment, contralateral o the hemisphere with predominant basal ganglia dysfunction. We plan to conduct control tests of motor- system and prefrontal function to ascertain the extent of independence of the occipital and parietal areas in affecting spatial function in PD. Further, we will conduct an exploration of the relation of visual and visuospatial impairments to daily function as assessed through self-report questionnaires and with an objective open-field measure of gait curvature. Assessment will occur at baseline and at one-year follow-up. We propose to examine the ability of 36 patients with left-onset PD (LPD), 36 with right-onset PD (RPD), 36 healthy age-matched adults, and 36 healthy young adults to perform on tests of vision and visuospatial function. Individuals with PD will likely exhibit poorer performance on most tests of vision and visuospatial function than age-matched adults, who in turn will exhibit poorer performance than young adults. We further expect that LPD will show more extensive visuospatial impairments than RPD, and that the pattern of impairments will distinguish the two subgroups. Our tests target visual and visuospatial symptoms reported by the patients themselves, ensuring that the elucidation of mechanisms will have clinical relevance. Demonstration of different profiles of performance in LPD and RPD would bolster arguments of selective visuospatial deficits in PD and suggest differential visual, cognitive, and functional enhancement strategies.
DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a common age-related neurodegenerative disorder in which multiple aspects of visuospatial cognitive function are impaired. Spatial dysfunction arises from pathological changes in high- order association areas of the brain but also from defective input from lower-level visual processing areas. Deficits in vision are prevalent in PD but virtually nothing is known about the relation between vision, cognition, and daily function in this disorder. Also unknown are the cognitive sequelae of the side of initial motor impairment, despite PD nearly always having unilateral onset of neurodegeneration and unequivocal evidence linking spatial abnormalities to right-hemisphere dysfunction. We propose a multi-level approach to examining visuospatial dysfunction in PD. One major focus is on the visuospatial consequences of visual deficits, specifically the reduced signal strength that results from contrast sensitivity loss. An innovative aspect of the study is our use of frequency doubling technology and optical coherence tomography to assess visual (including retinal) function. A second focus is on the side of onset of motor impairment, contralateral o the hemisphere with predominant basal ganglia dysfunction. We plan to conduct control tests of motor- system and prefrontal function to ascertain the extent of independence of the occipital and parietal areas in affecting spatial function in PD. Further, we will conduct an exploration of the relation of visual and visuospatial impairments to daily function as assessed through self-report questionnaires and with an objective open-field measure of gait curvature. Assessment will occur at baseline and at one-year follow-up. We propose to examine the ability of 36 patients with left-onset PD (LPD), 36 with right-onset PD (RPD), 36 healthy age-matched adults, and 36 healthy young adults to perform on tests of vision and visuospatial function. Individuals with PD will likely exhibit poorer performance on most tests of vision and visuospatial function than age-matched adults, who in turn will exhibit poorer performance than young adults. We further expect that LPD will show more extensive visuospatial impairments than RPD, and that the pattern of impairments will distinguish the two subgroups. Our tests target visual and visuospatial symptoms reported by the patients themselves, ensuring that the elucidation of mechanisms will have clinical relevance. Demonstration of different profiles of performance in LPD and RPD would bolster arguments of selective visuospatial deficits in PD and suggest differential visual, cognitive, and functional enhancement strategies.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alice Cronin-Golomb其他文献

Alice Cronin-Golomb的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alice Cronin-Golomb', 18)}}的其他基金

Effects of Parkinson's Disease on Perception, Cognition, and Gait
帕金森病对知觉、认知和步态的影响
  • 批准号:
    8321023
  • 财政年份:
    2009
  • 资助金额:
    $ 36.02万
  • 项目类别:
Effects of Parkinson's Disease on Perception, Cognition, and Gait
帕金森病对知觉、认知和步态的影响
  • 批准号:
    8132330
  • 财政年份:
    2009
  • 资助金额:
    $ 36.02万
  • 项目类别:
Effects of Parkinson's Disease on Perception, Cognition, and Gait
帕金森病对知觉、认知和步态的影响
  • 批准号:
    8534298
  • 财政年份:
    2009
  • 资助金额:
    $ 36.02万
  • 项目类别:
Effects of Parkinson's Disease on Perception, Cognition, and Gait
帕金森病对知觉、认知和步态的影响
  • 批准号:
    7770253
  • 财政年份:
    2009
  • 资助金额:
    $ 36.02万
  • 项目类别:
Visuospatial Function in Parkinson's Disease
帕金森病的视觉空间功能
  • 批准号:
    7392261
  • 财政年份:
    2006
  • 资助金额:
    $ 36.02万
  • 项目类别:
Visuospatial Function in Parkinson's Disease
帕金森病的视觉空间功能
  • 批准号:
    7582312
  • 财政年份:
    2006
  • 资助金额:
    $ 36.02万
  • 项目类别:
Visuospatial Function in Parkinson's Disease
帕金森病的视觉空间功能
  • 批准号:
    7799913
  • 财政年份:
    2006
  • 资助金额:
    $ 36.02万
  • 项目类别:
Visuospatial Function in Parkinson's Disease
帕金森病的视觉空间功能
  • 批准号:
    7183505
  • 财政年份:
    2006
  • 资助金额:
    $ 36.02万
  • 项目类别:
Visuospatial Function in Parkinson's Disease
帕金森病的视觉空间功能
  • 批准号:
    7774840
  • 财政年份:
    2006
  • 资助金额:
    $ 36.02万
  • 项目类别:
Optic Flow and Spatial Navigation in Parkinson's Disease
帕金森病的光流和空间导航
  • 批准号:
    6618615
  • 财政年份:
    2003
  • 资助金额:
    $ 36.02万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 36.02万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 36.02万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 36.02万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 36.02万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 36.02万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10390278
  • 财政年份:
    2021
  • 资助金额:
    $ 36.02万
  • 项目类别:
Evaluating the role of the caregiver in the quality of life of people with Parkinson?s disease: opportunities for intervention
评估护理人员在帕金森病患者生活质量中的作用:干预机会
  • 批准号:
    10088327
  • 财政年份:
    2020
  • 资助金额:
    $ 36.02万
  • 项目类别:
Evaluating the role of the caregiver in the quality of life of people with Parkinson?s disease: opportunities for intervention
评估护理人员在帕金森病患者生活质量中的作用:干预机会
  • 批准号:
    9907351
  • 财政年份:
    2020
  • 资助金额:
    $ 36.02万
  • 项目类别:
Dementia and hearing loss: Using preclinical models to uncover the mechanisms that accelerate cognitive decline in Alzheimer?s disease
痴呆和听力损失:利用临床前模型揭示加速阿尔茨海默病认知能力下降的机制
  • 批准号:
    429089
  • 财政年份:
    2019
  • 资助金额:
    $ 36.02万
  • 项目类别:
    Studentship Programs
Thalamic Contributions to Functional Network Abnormalities in Alzheimer''s Disease
丘脑对阿尔茨海默病功能网络异常的贡献
  • 批准号:
    10415553
  • 财政年份:
    2019
  • 资助金额:
    $ 36.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了